Sandford D. Smith - 02 Jan 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Reporting relationship: Director
Issuer ticker: CYTK
Reported as of: 02 Jan 2024
Net transaction value: +$12,450
SEC form: 4
Accepted by SEC: 03 Jan 2024, 16:25:31 UTC
Prior SEC filing: 03 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ John Faurescu, attorney-in-fact for Mr. Smith

Key filing fact

Sandford D. Smith filed Form 4 for CYTOKINETICS INC (CYTK) on 03 Jan 2024.

Key facts

This page summarizes Sandford D. Smith's Form 4 filing for CYTOKINETICS INC (CYTK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jan 2024, 16:25.

Change

Previous filing in this sequence was filed on 03 Oct 2023.
Current net transaction value: +$12,450.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYTK transaction

Common Stock

Award

Transaction value: $12,450
Shares: +148
Change %: +0.79%
Price: $84.12
Shares after: 18,801
Date: 02 Jan 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024.